Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmirtazapine in elderly subjects with chronic primary insomnia
NCT00561821Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of esmirtazapine in Insomnia, sponsored by Merck & Co. Started Nov 2007; status: completed.
02
Drugs
esmirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00561821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561821.